AlveoliX part of a new BRIDGE Discovery project

We are thrilled to be part of the new BRIDGE Discovery project granted by the SNSF Swiss National Science Foundation and Innosuisse to the Laboratory of Microbiology at the Université de Neuchâtel (LAMUN) in cooperation with the CHUV / Centre hospitalier universitaire vaudois, the SIB Swiss Institute of Bioinformatics, and SiMPLInext SA.  The project led by Prof. Pilar Junier aims at establishing a novel solution to the burden imposed by raising antibiotic resistance by applying the innovative concept of “environmental interference” to human

More

AlveoliX and EpiEndo Receive Eurostar Grant

Alveolix is excited to announce that the consortium project EPIcoliX in cooperation with EpiEndo Pharmaceuticals has been officially recognized as a Eurostar labelled project! AlveoliX will develop a new organ-on-a-chip model mimicking the colon epithelium of UC patients, which will be used for the screening of EpiEndo’s potential lead compounds with promising effects on gut epithelium. Find

More

AlveoliX in the Swiss Venture Capital Report 2021!

Despite the covid-19 crisis and no mega-rounds of investment in 2020, Biotech start-ups are back at the top!Swiss Biotech startups collected more than CHF 800 million in 2020, an increase of 31% compared to 2019. This is linked to the fact that innovation in drug development is taking place in the long term and, to

More

AlveoliX has a new Business Developer, Léa Todeschini

We are very excited to welcome Léa Todeschini as Business Developer in our team! Léa will be responsible for the growth and development of new business while maintaining customer relationships. We are looking forward to grow and further develop our company together with Léa. If you happen to be near our office, stop by and

More

Publication released in Annual Review

In this new work by Olivier Guenat and Thomas Geiser together with Francois Berthiaume, the possibilities of extracting clinically relevant tissue-level information from Organ on Chip devices are set into perspective. Check this enlightening work in “Clinically Relevant Tissue Scale Responses as New Readouts from Organs-on-a-Chip for Precision Medicine”. Learn more

More

AlveoliX receives the Innosuisse Certification

After having completed the phase of Core Coaching, we have been successfully certified as a company “ready for sustainable growth” by Innosuisse, The Swiss Innovation Agency. We are excited about the new growth phase ahead of us.

More

LOC platforms for inhalation assays

AlveoliX  innovative contribution for lung-on-chip based inhalation assays has been published in “Advanced in vitro lung-on-chip platforms for inhalation assays: From prospect to pipeline” in collaboration with the Israel Institute of Technology, ARTORG Center and Helmholtz Institute for Pharmaceutical Research Saarland. Learn more

More